News

Yahoo Finance8mon
Insignis Therapeutics Receives Positive FDA Feedback on IN-001 Clinical Program for Needle-Free Anaphylaxis Treatment - Yahoo Finance
NORTH HAVEN, Conn., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Insignis Therapeutics, a leader in innovative allergy and anaphylaxis treatments, announced today that it has received positive feedback from ...
Business Insider4y
Insignis Investigations achieves standard BS102000 (Code of practice for the provision of investigative services) certification from IQ Verify - Markets Insider
Insignis Investigations' Director said, "We're particularly pleased to have achieved British Standard 102000 certification as it underlines our commitment to our customers and our focus on quality.
Business Wire3y
Innovative Health Sciences to Showcase its State of the Art Insignis™ Syringe Infusion System at Medica 2021 - Business Wire
The Insignis –26G™ Subcutaneous Needle Sets are FDA cleared in the U.S. and IHS expects to receive full regulatory clearance for the entire Insignis™ system in the next few weeks.
The Business Journals1y
Kings Mountain OKs rezoning for Dixon Ridge mixed-use development - Charlotte Business Journal
Insignis Partners sought to rezone 384 acres in Kings Mountain to allow the development of Dixon Ridge, which proposes a mix of industrial, residential, and research and development space.
Yahoo Finance4y
Insignis Therapeutics and HLK Pharmacin Receive FDA IND Clearance to Initiate a Phase 1 Trial With IN-001 for Oral Anaphylaxis Treatment - Yahoo Finance
NORTH HAVEN, Conn. and NEW HAVEN, Conn., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Insignis Therapeutics (“Insignis”), a biotech company focused on developing innovative therapeutics for anaphylaxis ...